What is the address of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE?

The registered office of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE is located at Maretaklaan 47, 1180 Ukkel.

Is PROFESSEUR CLAUDE SCHULMAN-UROLOGIE still active?

Yes. According to the CBE (2 October 2026) PROFESSEUR CLAUDE SCHULMAN-UROLOGIE is active, legal situation “Normale toestand”, started on 6 May 2008.

Is PROFESSEUR CLAUDE SCHULMAN-UROLOGIE registered on Peppol?

No, PROFESSEUR CLAUDE SCHULMAN-UROLOGIE is currently not registered on the Peppol network.

What is the enterprise number of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE?

The enterprise number of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE is BE0897735295.

When was PROFESSEUR CLAUDE SCHULMAN-UROLOGIE founded?

PROFESSEUR CLAUDE SCHULMAN-UROLOGIE was founded on 6 May 2008.

Who are the directors of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE?

According to the 2025 annual accounts, the directors of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE are: Claude Schulman Charles.

Is PROFESSEUR CLAUDE SCHULMAN-UROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 May 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PROFESSEUR CLAUDE SCHULMAN-UROLOGIE make in 2025?

PROFESSEUR CLAUDE SCHULMAN-UROLOGIE posted a profit after taxes of € 1,316 in financial year 2025.

What is the revenue of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE?

As a small company, PROFESSEUR CLAUDE SCHULMAN-UROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,541.

PROFESSEUR CLAUDE SCHULMAN-UROLOGIE (Private Limited)

Dossier PROFESSEUR CLAUDE SCHULMAN-UROLOGIE, printed on 2 October 2026 from databakkes.be/en/0897735295/professeur-claude-schulman-urologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

PROFESSEUR CLAUDE SCHULMAN-UROLOGIE from Ukkel, company number BE0897735295, closed financial year 2025 with a result of € 1,316 after tax. For that financial year PROFESSEUR CLAUDE SCHULMAN-UROLOGIE recorded a gross margin of € 1,541 and equity of € 27,563. Compared with financial year 2024, the result moved from € -3,852 to € 1,316. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 27,563

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1,316

▲ still € 3,852 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 692

▲ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 8,963.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,158

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 726

▼ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -32,621 Gross margin 2022: € -32,621 First fiscal year in the series	€ 8,079 Gross margin 2023: € 8,079 ▲ € 40,700 vs 2022 (€ -32,621) Favourable step	€ -4,474 Gross margin 2024: € -4,474 ▼ € 12,553 vs 2023 (€ 8,079) Unfavourable step	€ 1,541 Gross margin 2025: € 1,541 ▲ € 6,016 vs 2024 (€ -4,474) Favourable step	▲ € 6,016
Profit after taxes	€ -35,825 Profit after taxes 2022: € -35,825 First fiscal year in the series	€ 5,166 Profit after taxes 2023: € 5,166 ▲ € 40,991 vs 2022 (€ -35,825) Favourable step	€ -3,852 Profit after taxes 2024: € -3,852 ▼ € 9,018 vs 2023 (€ 5,166) Unfavourable step	€ 1,316 Profit after taxes 2025: € 1,316 ▲ € 5,168 vs 2024 (€ -3,852) Favourable step	▲ € 5,168
Equity	€ 24,932 Equity 2022: € 24,932 First fiscal year in the series	€ 30,099 Equity 2023: € 30,099 ▲ 21% vs 2022 (€ 24,932) Favourable step	€ 26,247 Equity 2024: € 26,247 ▼ 13% vs 2023 (€ 30,099) Unfavourable step	€ 27,563 Equity 2025: € 27,563 ▲ 5% vs 2024 (€ 26,247) Favourable step	▲ 5%
Total debts	€ 4,375 Total debts 2022: € 4,375 First fiscal year in the series	€ 1,908 Total debts 2023: € 1,908 ▼ 56% vs 2022 (€ 4,375) Favourable step	€ 2,037 Total debts 2024: € 2,037 ▲ 7% vs 2023 (€ 1,908) Unfavourable step	€ 726 Total debts 2025: € 726 ▼ 64% vs 2024 (€ 2,037) Favourable step	▼ 64%
Cash	€ 11,320 Cash 2022: € 11,320 First fiscal year in the series	€ 11,058 Cash 2023: € 11,058 ▼ 2% vs 2022 (€ 11,320) Unfavourable step	€ 467 Cash 2024: € 467 ▼ 96% vs 2023 (€ 11,058) Unfavourable step	€ 692 Cash 2025: € 692 ▲ 48% vs 2024 (€ 467) Favourable step	▲ 48%
Retained profit	€ 6,332 Retained profit 2022: € 6,332 First fiscal year in the series	€ 11,499 Retained profit 2023: € 11,499 ▲ 82% vs 2022 (€ 6,332) Favourable step	€ 7,647 Retained profit 2024: € 7,647 ▼ 33% vs 2023 (€ 11,499) Unfavourable step	€ 8,963 Retained profit 2025: € 8,963 ▲ 17% vs 2024 (€ 7,647) Favourable step	▲ 17%
Bank debt	€ 765 Bank debt 2022: € 765 First fiscal year in the series	€ 1,099 Bank debt 2023: € 1,099 ▲ 44% vs 2022 (€ 765) Unfavourable step	€ 1,174 Bank debt 2024: € 1,174 ▲ 7% vs 2023 (€ 1,099) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 1,174) Favourable step	▼ 100%
Balance sheet total	€ 29,308 Balance sheet total 2022: € 29,308 First fiscal year in the series	€ 32,007 Balance sheet total 2023: € 32,007 ▲ 9% vs 2022 (€ 29,308) Unchanged	€ 28,284 Balance sheet total 2024: € 28,284 ▼ 12% vs 2023 (€ 32,007) Unchanged	€ 28,289 Balance sheet total 2025: € 28,289 Unchanged (€ 28,284) Unchanged

Key figures of PROFESSEUR CLAUDE SCHULMAN-UROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PROFESSEUR CLAUDE SCHULMAN-UROLOGIE?

What happened at PROFESSEUR CLAUDE SCHULMAN-UROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 1,316. Source: NBB ↗
May 6, 2008 Start of the company according to the CBE. KBO
2008 Claude Schulman Charles became a director. NBB

In short

From € 35,825 loss in 2022 to € 1,316 profit in 2025.

Paid € 0 in corporate taxes since 2022.

Best year ever: 2023, with € 5,166 profit.

Original PDFs at the National Bank ↗

A new publication or filing at PROFESSEUR CLAUDE SCHULMAN-UROLOGIE? We notify you, reason included.

Follow PROFESSEUR CLAUDE SCHULMAN-UROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Claude Schulman Charles

PROFESSEUR CLAUDE SCHULMAN-UROLOGIE

Behind PROFESSEUR CLAUDE SCHULMAN-UROLOGIE is Claude Schulman Charles.

See the full network in the app

Directors

According to the 2025 annual accounts

Claude Schulman Charles

Director

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Maretaklaan 47

1180 Ukkel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0897.735.295
VAT number: BE 0897.735.295
Registered office: Maretaklaan 47, 1180 Ukkel
Names & denominations: PROFESSEUR CLAUDE SCHULMAN-UROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 May 2008
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗